Quantitative assessment of lung density changes after 3-D radiotherapy for breast cancer

Acta Oncologica

Volumn 46, Issue 2, 2007, Pages 187-193

  Blom Goldman, Ulla ^a,b   Svane, Gunilla ^a,b   Wennberg, Berit ^a   Lideståhl, Anders ^a,b   Lind, Pehr A R M ^a,b,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; COVARIANCE; DISEASE SEVERITY; DOSE CALCULATION; DOSIMETRY; DRUG EXPOSURE; EVALUATION; FEMALE; FOLLOW UP; HUMAN; LUNG VOLUME; MAJOR CLINICAL STUDY; MORBIDITY; MULTIVARIATE ANALYSIS; PNEUMONIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; SYMPTOM; THORAX; THREE DIMENSIONAL RADIOTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LUNG; MIDDLE AGED; RADIATION PNEUMONITIS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33847075926     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860600949586     Document Type: Article

References (24)

1. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337:949-55.
2. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-62.
3. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999;353:1641-8.
4. Lind P. Clinical relevance of pulmonary toxicity in adjuvant breast cancer irradiation. Acta Oncol 2006;45:13-5.
5. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 2000;355:1757-70.
6. Gagliardi G. Modeling heart and lung complication data in radiation therapy of the breast. Stockholm: University of Stockholm; 1998. p. 61.
7. Lind P. Short-term pulmonary side-effects following radiation therapy in breast cancer. Stockholm: Karolinska Institute; 1999. p. 55.
8. Boersma L. Lung function and radiotherapy: An analysis of local and overall radition effects. Amsterdam: University of Vrije; 1995. p. 203.
9. Seppenwoolde Y. Radiation induced lung damage. Amsterdam: University of Amsterdam; 2002. p. 187.
10. Theuws J. Pulmonary effects of radiotherapy: A clinical analysis. Amsterdam: University of Vrije; 1999. p. 177.
11. Lind PA, Marks LB, Hardenbergh PH, Clough R, Fan M, Hollis D, et al. Technical factors associated with radiation pneumonitis after local +/- regional radiation therapy for breast cancer. Int J Radiat Oncol Biol Phys 2002;52:137-43.
12. Lind PA, Wennberg B, Gagliardi G, Fornander T. Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose. Breast Cancer Res Treat 2001;68:199-210.
13. Lind PA, Bylund H, Wennberg B, Svensson C, Svane G. Abnormalities on chest radiographs following radiation therapy for breast cancer. Eur Radiol 2000;10:484-9.
14. Lind PA, Svane G, Gagliardi G, Svensson C. Abnormalities by pulmonary regions studied with computer tomography following local or local-regional radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 1999;43:489-96.
15. Jarvenpaa R, Holli K, Pitkanen M, Hyodynmaa S, Rajala J, Lahtela SL, et al. Radiological pulmonary findings after breast cancer irradiation: A prospective study. Acta Oncol 2006;45:16-22.
16. Lind PA, Rosfors S, Wennberg B, Glas U, Bevegard S, Fornander T. Pulmonary function following adjuvant chemotherapy and radiotherapy for breast cancer and the issue of three-dimensional treatment planning. Radiother Oncol 1998;49:245-54.
17. Bentzen SM, Skoczylas JZ, Overgaard M, Overgaard J. Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst 1996;88:918-22.
18. Lind PA, Marks LB, Jamieson TA, Carter DL, Vredenburgh JJ, Folz RJ, et al. Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue. Cancer 2002;94:2821-9.
19. Taghian AG, Assaad SI, Niemierko A, Kuter I, Younger J, Schoenthaler R, et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst 2001;93:1806-11.
20. Cancer Therapy Evaluation Program. Common toxicity criteria, Version 2.0 DCTD, NCI, DHHS. Accessable at: http://ctep.cancer.gov
21. Arriagada R, de Guevara JC, Mouriesse H, Hanzen C, Couanet D, Ruffie P, et al. Limited small cell lung cancer treated by combined radiotherapy and chemotherapy: Evaluation of a grading system of lung fibrosis. Radiother Oncol 1989;14:1-8.
22. Prochazka M, Hall P, Gagliardi G, Granath F, Nilsson BN, Shields PG, et al. Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: Case-only design. J Clin Oncol 2005;23:7467-74.
23. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005;366:2087-106.
24. Johansson S, Bjermer L, Franzen L, Henriksson R. Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients. Radiother Oncol 1998;49:41-7.